Followers | 3817 |
Posts | 147294 |
Boards Moderated | 5 |
Alias Born | 08/05/2009 |
Recent ELEV News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/22/2023 08:30:21 PM
- Elevation Oncology to Present at the H.C. Wainwright 25th Annual Global Investment Conference • PR Newswire (US) • 09/05/2023 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/16/2023 11:45:12 AM
- Elevation Oncology Announces First Patient Dosed in the Phase 1 Clinical Trial Evaluating EO-3021 • PR Newswire (US) • 08/16/2023 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/03/2023 11:45:22 AM
- Elevation Oncology Reports Second Quarter 2023 Financial Results and Highlights Recent Business Achievements • PR Newswire (US) • 08/03/2023 11:30:00 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/03/2023 11:15:41 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/03/2023 11:01:10 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/14/2023 08:29:20 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 07/14/2023 08:26:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 12:15:30 PM
- Elevation Oncology Appoints Joseph Ferra as Chief Executive Officer and Promotes Tammy Furlong to Chief Financial Officer • PR Newswire (US) • 07/13/2023 12:00:00 PM
- Elevation Oncology Announces Pricing of $50 Million Public Offering • PR Newswire (US) • 06/09/2023 02:41:00 AM
- Elevation Oncology Announces Launch of Proposed Public Offering • PR Newswire (US) • 06/08/2023 08:01:00 PM
- Elevation Oncology Highlights First-in-Human Phase 1 SYSA1801 (EO-3021) Clinical Data to be Presented by Partner CSPC Pharmaceutical Group Limited at ASCO 2023 • PR Newswire (US) • 06/03/2023 01:00:00 PM
- Elevation Oncology Reports First Quarter 2023 Financial Results and Highlights Recent Business Achievements • PR Newswire (US) • 05/15/2023 11:30:00 AM
- Elevation Oncology Highlights Clinical Data for SYSA1801 (EO-3021) to be Presented by Partner CSPC Pharmaceutical Group Limited at ASCO 2023 • PR Newswire (US) • 04/26/2023 08:05:00 PM
- Elevation Oncology Presents EO-3021 Preclinical Proof-of-Concept Data and Highlights a Clinical Case Study in Claudin 18.2-Expressing Cancers at AACR 2023 • PR Newswire (US) • 04/17/2023 02:15:00 PM
- Elevation Oncology to Present at the American Association of Cancer Research (AACR) Annual Meeting 2023 • PR Newswire (US) • 03/14/2023 08:30:00 PM
- Elevation Oncology Reports Fourth Quarter and Full Year 2022 Financial Results • PR Newswire (US) • 03/09/2023 12:30:00 PM
- Elevation Oncology to Participate at Upcoming Investor Conferences • PR Newswire (US) • 03/01/2023 12:00:00 PM
- Elevation Oncology to Present at the SVB Securities Global Biopharma Conference • PR Newswire (US) • 02/08/2023 12:00:00 PM
- Elevation Oncology to Present at the 41st Annual J.P. Morgan Healthcare Conference • PR Newswire (US) • 01/09/2023 12:30:00 PM
- Elevation Oncology Announces Pipeline Prioritization, Realignment of Resources to Advance EO-3021 and CEO Transition • PR Newswire (US) • 01/06/2023 01:15:00 PM
- Elevation Oncology to Participate at the JMP Securities Hematology and Oncology Summit • PR Newswire (US) • 11/30/2022 12:30:00 PM
FEATURED Cannabix's MSBS Marijuana Breathalyzer Technology Advances Quantification of THC in Breath • Oct 3, 2023 8:50 AM
Strategic Joint Venture Signed by Santo Mining Corp. and Planta Vida S.A.S. • SANP • Oct 3, 2023 3:00 PM
Good Gaming, Inc. Announces Galactic Acres™ as Its First Mobile Game Integrated with Web3 Technology • GMER • Oct 3, 2023 8:30 AM
HealthLynked Announces Patent Filing for ARI: A Revolutionary AI-Powered Healthcare Interface • HLYK • Oct 3, 2023 8:00 AM
Nate's Food Co Successfully Completes Cancellation of 1 Billion Common Shares, Paving the Way for a Bright Future • NHMD • Oct 3, 2023 8:00 AM
Branded Legacy Expands Facility to 11,000 Sqft, Extends LOI for Acquisition of The Alcannabist LLC • BLEG • Oct 3, 2023 8:00 AM